MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
89.7 M |
Market Cap[1] |
$ 756 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Johnson & Johnson
JNJ
|
$ 276.4 | 3.84 % | $ 665 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.18 | 3.06 % | $ 1.47 M | Nasdaq Global Select Market | USA |
 |
Xencor
XNCR
|
$ 34.95 | 14.07 % | $ 2.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Keros Therapeutics
KROS
|
$ 10.89 | 0.55 % | $ 405 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 307.81 | 0.91 % | $ 8.91 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 7.73 | -21.76 % | $ 678 M | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 8.08 | -0.25 % | $ 122 M | Nasdaq Global Select Market |  Australia |
 |
Compugen Ltd.
CGEN
|
$ 2.03 | 1.0 % | $ 190 M | Nasdaq Global Market,SPB |  Israel |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.03 | 1.98 % | $ 237 M | NYSE American | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
Eli Lilly and Company
LLY
|
$ 1 421.98 | 0.89 % | $ 1.28 T | NYSE,SPB | USA |
 |
Liquidia Corporation
LQDA
|
$ 47.41 | 12.35 % | $ 4.08 B | Nasdaq Capital Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.42 | 1.98 % | $ 2.06 M | Nasdaq Global Market | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Mirum Pharmaceuticals
MIRM
|
$ 97.21 | 11.7 % | $ 4.88 B | Nasdaq Global Select Market | USA |
 |
MediciNova
MNOV
|
$ 1.46 | 2.82 % | $ 71.6 M | Nasdaq Global Market | USA |
 |
Monopar Therapeutics
MNPR
|
$ 72.21 | 3.32 % | $ 535 M | Nasdaq Global Select Market | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
Moderna
MRNA
|
$ 258.45 | 13.14 % | $ 101 B | Nasdaq Global Select Market,SPB | USA |
 |
CorMedix
CRMD
|
$ 5.66 | 1.62 % | $ 408 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 51.69 | 3.4 % | $ 4.65 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Nektar Therapeutics
NKTR
|
$ 38.45 | 1.83 % | $ 649 M | Nasdaq Global Select Market,SPB | USA |
|
Champions Oncology
CSBR
|
$ 4.84 | 0.21 % | $ 66.9 M | Nasdaq Capital Market | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Novartis AG
NVS
|
$ 164.87 | 3.52 % | $ 320 B | NYSE | Schweiz |
 |
Curis
CRIS
|
$ 1.11 | 54.78 % | $ 14.6 M | Nasdaq Global Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.42 | 8.87 % | $ 40.3 M | Nasdaq Global Select Market |  Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 9.34 | -2.61 % | $ 820 M | Nasdaq Global Select Market | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | Israel |
 |
Pfizer
PFE
|
$ 30.74 | 2.47 % | $ 175 B | NYSE,SPB | USA |
|
Phathom Pharmaceuticals
PHAT
|
$ 5.68 | -1.13 % | $ 414 M | Nasdaq Global Select Market,SPB | USA |
 |
Cabaletta Bio
CABA
|
$ 1.42 | 0.35 % | $ 143 M | Nasdaq Global Select Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.85 | -1.71 % | $ 52.2 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Prothena Corporation plc
PRTA
|
$ 8.39 | 2.13 % | $ 452 M | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Protagonist Therapeutics
PTGX
|
$ 143.39 | 2.04 % | $ 9.12 B | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.08 | -0.46 % | $ 94.1 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.61 | 3.78 % | $ 290 M | Nasdaq Global Select Market | USA |
 |
Arcus Biosciences
RCUS
|
$ 19.17 | 1.37 % | $ 2.06 B | NYSE,SPB | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.76 | 3.18 % | $ 12.3 B | NYSE |  India |
 |
Replimune Group
REPL
|
$ 20.68 | 0.12 % | $ 1.92 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Avidity Biosciences
RNA
|
$ 8.67 | -0.57 % | $ 1.19 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.